MedPath

ACCEL-SEVELAMER

ACCEL-SEVELAMER

Approved
DIN Number

02461501

Drug Class

Human

Market Date

Nov 8, 2017

Company
HC

accel pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02461501
AIG Number0152763001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AE02 SEVELAMER
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:18.19
Health Canada Classification

ACTIVE INGREDIENTS (1)

SEVELAMER CARBONATEActive
Strength: 800 MG
Monograph: SEVELAMER CARBONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.